Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Evogene Ltd. Report Publication Announcement 2017

Jul 20, 2017

6785_rns_2017-07-20_c8d7627b-3cf9-406e-86b4-35bfe6e5113c.htm

Report Publication Announcement

Open in viewer

Opens in your device viewer

_________ false

����� ��"� 2 381
EVOGENE LTD
Corporation no: 512838723 11441
- - -
Israel Securities Authority Tel Aviv Stock Exchange C003 ( Public ) Reported via MAGNA: 20/07/2017
www.isa.gov.il www.tase.co.il Reference: 2017-02-075528 Time of broadcast: 14:03 13:51:59

Other Report or AnnouncementRegulation 5 of the Securities Regulations, (Periodic and Immediate Reports of Foreign Corporation) 5761-2000

The corporation is a foreign private issuer as defined by U.S. Securities Laws.
Attached hereto is a report on Second Quarter 2017 Earnings Announcement Schedule

Q217_Results_Schedule_isa.pdf

References of previous documents relating to this matter(the reference does not constitute incorporation by reference):
- - -
Stock Exchange/Market: -1 Date of revision of form structure: 16/07/2017
Address: Gad Feinstein St 13, P.O.B 2100 , Rehovot 76121   , Tel: 08-9311900 , Fax: 08-9466724
E-mail address: [email protected]   Company site: www.evogene.com
Previous names of reporting entity:
Name of the Signatory: Bartov Pinto Amitai Position of Signatory in the reporting corporation: Attorney/Legal Counsel Name of Employer Company:
Address: Gad Feinstein 13 , Rehovot 7612002 Telephone: 08-9311962 Facsimile: 08-9466724 E-mail: [email protected] 1